A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 299 participants.
Also called NCT06326047
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 299 participants
- Sponsor
- Registry
-
NCT06326047 -
jRCT2031230704
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Australia, Canada, India, Japan, South Africa, South Korea
- Registry status
- Completed
Technical summary
Registry record NCT06326047. Randomized; quadruple masking; primary purpose treatment. Start 2024-03-18 (actual); primary completion 2025-09-19 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- NNC0519-0130
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Trizepatide
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct06326047- Content hash
521c3228e7c596c1f1d08ada857bea55ba5b1c2eb7c95aa330bf1d50c603365c